S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
Log in

CELYAD SA/ADR News Headlines (NASDAQ:CYAD)

$9.65
-0.23 (-2.33 %)
(As of 02/25/2020 04:00 PM ET)
Today's Range
$9.65
Now: $9.65
$9.88
50-Day Range
$9.88
MA: $10.92
$12.42
52-Week Range
$8.10
Now: $9.65
$22.99
Volume174 shs
Average Volume24,433 shs
Market Capitalization$134.52 million
P/E RatioN/A
Dividend YieldN/A
Beta1.23

Headlines

CELYAD SA/ADR (NASDAQ CYAD) News Headlines

Source:
DateHeadline
Celyad: Assessing This CAR-T ConcernCelyad: Assessing This CAR-T Concern
seekingalpha.com - February 4 at 7:55 PM
Celyad Successfully Doses First Patient with CYAD-02 in CYCLE-1 Trial for r/r AML and MDSCelyad Successfully Doses First Patient with CYAD-02 in CYCLE-1 Trial for r/r AML and MDS
finance.yahoo.com - January 13 at 3:04 AM
Celyad updates on NKG2D-based CAR-T therapyCelyad updates on NKG2D-based CAR-T therapy
seekingalpha.com - December 10 at 10:34 AM
Celyad Presents Update on r/r AML and MDS Program at 61st ASH Annual MeetingCelyad Presents Update on r/r AML and MDS Program at 61st ASH Annual Meeting
finance.yahoo.com - December 9 at 10:00 PM
Celyad Receives Additional €2.5 Million in Non-Dilutive FundingCelyad Receives Additional €2.5 Million in Non-Dilutive Funding
finance.yahoo.com - December 6 at 7:31 AM
Celyad SA (CYAD) Moves to Buy: Rationale Behind the UpgradeCelyad SA (CYAD) Moves to Buy: Rationale Behind the Upgrade
finance.yahoo.com - November 13 at 11:58 AM
BRIEF-Celyad Highlights Safety And Clinical Activity Of CYAD-101BRIEF-Celyad Highlights Safety And Clinical Activity Of CYAD-101
www.msn.com - November 11 at 9:38 AM
Celyad to Present Update to r/r AML and MDS Program at 2019 ASH Annual MeetingCelyad to Present Update to r/r AML and MDS Program at 2019 ASH Annual Meeting
finance.yahoo.com - November 6 at 9:07 AM
Celyad Highlights Abstracts from mCRC Clinical Program Released for SITC 34th Annual MeetingCelyad Highlights Abstracts from mCRC Clinical Program Released for SITC 34th Annual Meeting
finance.yahoo.com - November 5 at 8:03 AM
The Week Ahead In Biotech: Smid-Cap Earnings Deluge, SITC Conference In The SpotlightThe Week Ahead In Biotech: Smid-Cap Earnings Deluge, SITC Conference In The Spotlight
www.msn.com - November 3 at 1:01 PM
Does Celyad SA (EBR:CYAD) Have A Volatile Share Price?Does Celyad SA (EBR:CYAD) Have A Volatile Share Price?
finance.yahoo.com - October 22 at 3:43 AM
Celyad Announces October and November 2019 Investor Conference ScheduleCelyad Announces October and November 2019 Investor Conference Schedule
finance.yahoo.com - October 11 at 7:48 AM
Celyad to Present Update on mCRC Clinical Program at the 2019 SITC Annual MeetingCelyad to Present Update on mCRC Clinical Program at the 2019 SITC Annual Meeting
finance.yahoo.com - October 11 at 7:48 AM
Celyad Announces Closing of $20 Million Global OfferingCelyad Announces Closing of $20 Million Global Offering
finance.yahoo.com - September 17 at 5:15 AM
 Celyad Announces Pricing of $20.0 Million Global Offering Celyad Announces Pricing of $20.0 Million Global Offering
finance.yahoo.com - September 12 at 10:22 AM
The Daily Biotech Pulse: Lexicon Snaps Sanofi Diabetes Partnership With $260M Settlement, Celyad Offering, Multiple Sclerosis Conference Gets UnderwayThe Daily Biotech Pulse: Lexicon Snaps Sanofi Diabetes Partnership With $260M Settlement, Celyad Offering, Multiple Sclerosis Conference Gets Underway
finance.yahoo.com - September 11 at 11:16 AM
Celyad Successfully Doses First Patient with CYAD-01 Produced with OptimAb Manufacturing ProcessCelyad Successfully Doses First Patient with CYAD-01 Produced with OptimAb Manufacturing Process
finance.yahoo.com - September 4 at 8:11 AM
Celyad Reports Half Year 2019 Financial Results and Second Quarter Business HighlightsCelyad Reports Half Year 2019 Financial Results and Second Quarter Business Highlights
finance.yahoo.com - August 22 at 4:15 PM
Some Celyad (EBR:CYAD) Shareholders Have Taken A Painful 71% Share Price DropSome Celyad (EBR:CYAD) Shareholders Have Taken A Painful 71% Share Price Drop
finance.yahoo.com - August 22 at 9:53 AM
Celyad provides update on CAR-T therapies in solid tumorsCelyad provides update on CAR-T therapies in solid tumors
seekingalpha.com - July 6 at 10:23 AM
Celyad Presents Update on Autologous & Allogeneic NKG2D-based CAR-T Therapies in Solid TumorsCelyad Presents Update on Autologous & Allogeneic NKG2D-based CAR-T Therapies in Solid Tumors
finance.yahoo.com - July 5 at 10:48 AM
Celyad to Host Conference Call to Review Clinical Update from ESMO 21st World GI CongressCelyad to Host Conference Call to Review Clinical Update from ESMO 21st World GI Congress
finance.yahoo.com - July 2 at 4:44 PM
Celyad SA Sees Hammer Chart Pattern: Time to Buy?Celyad SA Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - June 21 at 3:58 PM
Celyad Presents Clinical Update for CYAD-01 at 24th Congress of the European Hematology AssociationCelyad Presents Clinical Update for CYAD-01 at 24th Congress of the European Hematology Association
finance.yahoo.com - June 17 at 4:34 PM
Celyad Sees Hammer Chart Pattern: Time to Buy?Celyad Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - June 3 at 11:00 AM
Celyad to Present Data at 24th Congress of the European Hematology AssociationCelyad to Present Data at 24th Congress of the European Hematology Association
finance.yahoo.com - May 16 at 4:11 PM
Celyad Announces First Quarter 2019 Financial Results and Recent Business HighlightsCelyad Announces First Quarter 2019 Financial Results and Recent Business Highlights
finance.yahoo.com - May 9 at 11:52 AM
Celyad Announces May 2019 Investor Conference ScheduleCelyad Announces May 2019 Investor Conference Schedule
finance.yahoo.com - May 2 at 4:19 PM
Celyad to Present Update on allogeneic and autologous NKG2D-based CAR-T Candidates in Refractory mCRC at ESMO 21st World GI CongressCelyad to Present Update on allogeneic and autologous NKG2D-based CAR-T Candidates in Refractory mCRC at ESMO 21st World GI Congress
finance.yahoo.com - April 17 at 4:18 PM
Celyad Announces April 2019 Investor Conference ScheduleCelyad Announces April 2019 Investor Conference Schedule
finance.yahoo.com - April 1 at 6:26 PM
Celyad Appoints Filippo Petti as Chief Executive OfficerCelyad Appoints Filippo Petti as Chief Executive Officer
finance.yahoo.com - March 29 at 12:33 PM
Celyad Reports Business Update and Full Year 2018 Financial and Operating ResultsCelyad Reports Business Update and Full Year 2018 Financial and Operating Results
finance.yahoo.com - March 29 at 12:33 PM
Celyad’s 2019 R&D Day Highlights shRNA Platform and Pipeline of Next-generation NKG2D-based and Off-the-Shelf Non-gene Edited CAR-T CandidatesCelyad’s 2019 R&D Day Highlights shRNA Platform and Pipeline of Next-generation NKG2D-based and Off-the-Shelf Non-gene Edited CAR-T Candidates
finance.yahoo.com - March 19 at 9:51 AM
Celyad to Host R&D Day and Webcast on Monday, March 18 in New York CityCelyad to Host R&D Day and Webcast on Monday, March 18 in New York City
finance.yahoo.com - March 11 at 8:19 AM
Celyad Appoints Anne Moore as Vice President Corporate StrategyCelyad Appoints Anne Moore as Vice President Corporate Strategy
finance.yahoo.com - March 8 at 12:19 PM
Celyad Announces February and March 2019 Investor Conference ScheduleCelyad Announces February and March 2019 Investor Conference Schedule
finance.yahoo.com - February 22 at 1:01 PM
Celyad Outlines Key 2019 Priorities Including the Acceleration of the CYAD-01 Program in r/r AML and MDSCelyad Outlines Key 2019 Priorities Including the Acceleration of the CYAD-01 Program in r/r AML and MDS
finance.yahoo.com - January 7 at 10:32 AM
This page was last updated on 2/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel